180 related articles for article (PubMed ID: 25139324)
1. Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists.
Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
Int J Cardiol; 2014 Oct; 176(3):1259-61. PubMed ID: 25139324
[No Abstract] [Full Text] [Related]
2. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
3. Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
Sani M; Ayubi E; Mansori K; Khazaei S
Int J Cardiol; 2016 Nov; 222():949. PubMed ID: 27526365
[No Abstract] [Full Text] [Related]
4. Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation.
Guo Y; Zhu H; Chen Y; Lip GYH
Am J Med; 2018 Feb; 131(2):185-192. PubMed ID: 28943382
[TBL] [Abstract][Full Text] [Related]
5. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
[TBL] [Abstract][Full Text] [Related]
6. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
7. Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso.
Yameogo AR; Kologo JK; Mandi G; Kabore HP; Millogo GR; Seghda AA; Samadoulougou AK; Zabsonre P
Pan Afr Med J; 2016; 24():108. PubMed ID: 27642447
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of vitamin K antagonist in patients with atrial fibrillation and liver cirrhosis.
Lee SJ; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
Int J Cardiol; 2015 Feb; 180():185-91. PubMed ID: 25463361
[TBL] [Abstract][Full Text] [Related]
9. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
Guo Y; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
[TBL] [Abstract][Full Text] [Related]
10. Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.
Gussoni G; Di Pasquale G; Vescovo G; Gulizia M; Mathieu G; Scherillo M; Panuccio D; Lucci D; Nozzoli C; Fabbri G; Colombo F; Riva L; Baldo CI; Maggioni AP; Mazzone A;
Eur J Intern Med; 2013 Jun; 24(4):324-32. PubMed ID: 23684591
[TBL] [Abstract][Full Text] [Related]
11. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
12. Weighing the risks: Thrombotic and bleeding events in adults with atrial arrhythmias and congenital heart disease.
Heidendael JF; Bokma JP; de Groot JR; Koolbergen DR; Mulder BJ; Bouma BJ
Int J Cardiol; 2015; 186():315-20. PubMed ID: 25838183
[TBL] [Abstract][Full Text] [Related]
13. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
[TBL] [Abstract][Full Text] [Related]
14. Bleeding risks associated with vitamin K antagonists.
Linkins LA
Blood Rev; 2013 May; 27(3):111-8. PubMed ID: 23473948
[TBL] [Abstract][Full Text] [Related]
15. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
16. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
[TBL] [Abstract][Full Text] [Related]
17. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
[TBL] [Abstract][Full Text] [Related]
18. [Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].
MMW Fortschr Med; 2011 Sep; 153(37):16. PubMed ID: 21950182
[No Abstract] [Full Text] [Related]
19. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
Korin J
Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management].
Soave C; Chidlovskii E; Lebelhomme A; Gaboreau Y; Pernod G; Bosson JL; Couturier P
Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13(3):279-88. PubMed ID: 26395301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
